Mindpeak and Revolune launch co-selling deal for spatial biology workflow

Mindpeak and Revolune said they will co-sell an integrated workflow that pairs multiplex tissue staining with AI image analysis for spatial biology research. The partnership is aimed at speeding analysis of tumor microenvironments, ADC studies and biomarker discovery.

Why it matters: - The partnership packages staining and analysis into one workflow, which can shorten the path from tissue preparation to spatial readouts. - The combined offering is aimed at translational teams, CROs and researchers working on tumor immune microenvironment studies, antibody-drug conjugates and biomarker discovery. - The deal may reduce reliance on separate bioinformatics pipelines and manual analysis steps.

What happened: - Mindpeak and Revolune announced a commercial co-selling partnership on September 21, 2026. - The companies will offer Mindpeak’s PhenoScout™ AI platform alongside Revolune’s multiplex reagent kits. - The workflow combines multiplex tissue staining with AI-powered image analysis. - Revolune will offer qualifying customers promotional PhenoScout AI analysis credits when they buy eligible multiplex IF kits. - The launch promotion is designed to let researchers test the workflow on their own tissue samples before moving to annual subscription packages. - More information is available at the company’s announcement.

The details: - Revolune’s kits are positioned as a faster path from validated primary antibodies to ready-to-use 4- to 7-plex kits. - PhenoScout AI automates cell detection, tumor/stroma segmentation, phenotyping and spatial neighborhood metrics. - Mindpeak says the analysis can run in minutes. - The platform is designed to remove the need for bioinformatics pipelines or manual thresholding. - Revolune described its role as simplifying the generation of high-quality multiplex immunofluorescence data. - Mindpeak described PhenoScout as using pre-trained foundation models for turnkey spatial analysis. - PhenoScout AI is developed by Mindpeak and available through Revolune. - The offering is for Research Use Only, or RUO.

Between the lines: - The partnership reflects a broader push in spatial biology toward more integrated, end-to-end workflows. - Packaging validated staining chemistry with AI analysis may help labs adopt multiplex immunofluorescence without building custom informatics infrastructure. - The co-selling model also gives both companies a way to reach researchers earlier in the workflow, not just at the analysis stage.

What’s next: - Researchers can use the introductory promotion to evaluate the combined stain-to-insight workflow. - Labs that trial the system may later move to flexible annual subscription packages. - The companies are betting that easier workflow adoption will support cohort-scale studies and broader use of spatial biology tools.

The bottom line: - Mindpeak and Revolune are trying to make spatial biology more usable by connecting multiplex staining and AI analysis in a single commercial package.